tiprankstipranks
Advertisement
Advertisement
Tectonic Therapeutic chair Terry McGuire to retire, Francois Nader to succeed
PremiumThe FlyTectonic Therapeutic chair Terry McGuire to retire, Francois Nader to succeed
2M ago
Buy Rating on Tectonic: Differentiated TX45 Strategy, Favorable PK Profile, and Sufficient Cash Runway to Phase 2 Readouts
Premium
Ratings
Buy Rating on Tectonic: Differentiated TX45 Strategy, Favorable PK Profile, and Sufficient Cash Runway to Phase 2 Readouts
3M ago
Tectonic Therapeutic price target lowered to $60 from $64 at Truist
Premium
The Fly
Tectonic Therapeutic price target lowered to $60 from $64 at Truist
4M ago
Tectonic Therapeutic Reports Positive Phase 1b Trial Results
PremiumCompany AnnouncementsTectonic Therapeutic Reports Positive Phase 1b Trial Results
6M ago
Promising Phase 1b Trial Results and Market Expansion Justify Buy Rating for Tectonic Therapeutic
Premium
Ratings
Promising Phase 1b Trial Results and Market Expansion Justify Buy Rating for Tectonic Therapeutic
6M ago
Tectonic Therapeutic Inc trading resumes
Premium
The Fly
Tectonic Therapeutic Inc trading resumes
6M ago
Tectonic Therapeutic initiated with an Outperform at Oppenheimer
PremiumThe FlyTectonic Therapeutic initiated with an Outperform at Oppenheimer
8M ago
Confidence in Tectonic Therapeutic’s Strategic Approach Amid Eli Lilly’s Trial Setback
Premium
Ratings
Confidence in Tectonic Therapeutic’s Strategic Approach Amid Eli Lilly’s Trial Setback
8M ago
Tectonic pullback on Eli Lilly relaxin data ‘overdone,’ says Truist
Premium
The Fly
Tectonic pullback on Eli Lilly relaxin data ‘overdone,’ says Truist
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100